Adjuvant GEMOX for biliary tract cancer: Updated relapse-free survival and first overall survival results of the randomized PRODIGE 12-ACCORD 18 (UNICANCER GI) phase III trial

Affiliation auteurs!!!! Error affiliation !!!!
TitreAdjuvant GEMOX for biliary tract cancer: Updated relapse-free survival and first overall survival results of the randomized PRODIGE 12-ACCORD 18 (UNICANCER GI) phase III trial
Type de publicationJournal Article
Year of Publication2017
AuteursEdeline J., Bonnetain F., Phelip J-M., Watelet J., Hammel P., Joly J-P., Benabdelghani M., Fartoux L., Bouhier-Leporrier K., Jouve J-L., Faroux R., Guerin-Meyer V., Assenat E., Seitz J-F., Malka D., Louvet C., Bertaut A., Juzyna B., Stanbury T., Boucher E.
JournalANNALS OF ONCOLOGY
Volume28
Date PublishedSEP
Type of ArticleMeeting Abstract
ISSN0923-7534